# Cumberland Pharmaceuticals Inc: Form 8-K, filed Mar 8, 2022

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2022-03-08
- Accepted by EDGAR: Mar 8, 2022, 17:15 ET
- Period: 2022-03-08
- Accession: 0001628280-22-005405
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828022005405/cpix-20220308.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828022005405/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828022005405/cpix-20220308.htm

Filed Mar 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-005405. Last ingested by Listed: Oct 26, 2026, 16:41 ET. No prices; not investment advice.